Wells Fargo Initiates Coverage of Natera (NTRA) with Equal-Weight Recommendation

Wells Fargo initiated 'Equal-Weight' coverage on Natera (NTRA) on September 22, 2025, setting an average one-year price target of $201.84, which implies a 12.64% upside from its $179.20 close. This outlook comes despite projected annual revenue decreasing by 23.99% to $1,493MM and a non-GAAP EPS of -$4.02. Institutional sentiment remains bullish, with 1,351 funds increasing positions by 6.04% quarter-over-quarter, total institutional shares rising by 1.98%, and a put/call ratio of 0.37, further supported by significant increases in holdings by major investors like Price T Rowe Associates and JPMorgan Chase.

Analysis

Natera (NTRA) presents a significant divergence between its projected financial performance and current institutional sentiment. Wells Fargo has initiated coverage with a neutral 'Equal-Weight' recommendation, while the average analyst price target of $201.84 implies a modest 12.64% upside, albeit with a very wide forecast range from $37.37 to $267.75, indicating high uncertainty. This cautious analyst outlook is juxtaposed against a starkly negative fundamental projection, with annual revenue forecast to decline by 23.99% to $1,493MM and a projected non-GAAP EPS of -$4.02. In direct contrast, institutional sentiment is strongly bullish. The number of funds holding NTRA increased by 6.04% in the last quarter, total institutional share ownership rose by 1.98%, and the average portfolio weight dedicated to the stock grew by 12.81%. This trend is underscored by aggressive buying from major institutions like JPMorgan Chase and its Large Cap Growth Fund, which increased their portfolio allocations by 54.42% and 111.74% respectively. The bullish options market sentiment, reflected in a low put/call ratio of 0.37, further reinforces the view that many investors are positioning for upside despite the deteriorating financial projections.

Key Decisions for Investors

• Investors should recognize the high-risk dynamic in Natera, where strong institutional momentum and a bullish options market are directly at odds with sharply negative forward guidance on revenue and earnings.
• Given the 'Equal-Weight' rating and deteriorating fundamentals, long-term, value-oriented investors should exercise caution, while momentum-driven traders might follow the strong institutional flows but should be prepared for volatility.
• It is critical to monitor for any revisions to the company's revenue and EPS projections, as a positive update could validate the institutional buying, whereas a failure to improve could trigger a rapid exit by these same funds.